Debt-to-equity of Dogwood Therapeutics, Inc. from 30 Sep 2021 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Dogwood Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2021 to 30 Sep 2025.
  • Dogwood Therapeutics, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 658%, a 2412% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Dogwood Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 658% +632% +2412% 30 Sep 2025
Q2 2025 1247% +1234% +9248% 30 Jun 2025
Q1 2025 4399% +4387% +36068% 31 Mar 2025
Q4 2024 -958% -968% -9723% 31 Dec 2024
Q3 2024 26% +15% +129% 30 Sep 2024
Q2 2024 13% -0.42% -3.1% 30 Jun 2024
Q1 2024 12% -5.1% -30% 31 Mar 2024
Q4 2023 10% -8.8% -47% 31 Dec 2023
Q3 2023 11% -4.7% -29% 30 Sep 2023
Q2 2023 14% +1.5% +12% 30 Jun 2023
Q1 2023 17% +9.4% +119% 31 Mar 2023
Q4 2022 19% +13% +242% 31 Dec 2022
Q3 2022 16% +11% +229% 30 Sep 2022
Q2 2022 12% 30 Jun 2022
Q1 2022 7.9% 31 Mar 2022
Q4 2021 5.5% 31 Dec 2021
Q3 2021 4.9% 30 Sep 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.